These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36240439)

  • 41. Reversal of the anticoagulant effects of warfarin by vitamin K1.
    Hirsh J
    Chest; 1998 Dec; 114(6):1505-8. PubMed ID: 9872176
    [No Abstract]   [Full Text] [Related]  

  • 42. Warfarin and extractions.
    Malden NJ
    Br Dent J; 2003 Jan; 194(2):65. PubMed ID: 12596738
    [No Abstract]   [Full Text] [Related]  

  • 43. The changing face of anticoagulation management: an improving countenance.
    Baker WL
    Pharmacotherapy; 2013 Nov; 33(11):1133-5. PubMed ID: 24590595
    [No Abstract]   [Full Text] [Related]  

  • 44. Achievement of therapeutic international normalized ratio following adjustment of tube feeds.
    Krajewski KC; Butterfoss K
    J Clin Pharmacol; 2011 Mar; 51(3):440-3. PubMed ID: 20538908
    [No Abstract]   [Full Text] [Related]  

  • 45. Home anticoagulation monitoring is safe and effective.
    Harv Heart Lett; 2000 Dec; 11(4):4-5. PubMed ID: 11114792
    [No Abstract]   [Full Text] [Related]  

  • 46. Change in International Normalized Ratio Among Patients Treated With Dicloxacillin and Vitamin K Antagonists.
    Pottegård A; Henriksen DP; Madsen KG; Hellfritzsch M; Damkier P; Stage TB
    JAMA; 2015 Jul; 314(3):296-7. PubMed ID: 26197191
    [No Abstract]   [Full Text] [Related]  

  • 47. International normalized ratio stabilization in newly initiated warfarin patients with nonvalvular atrial fibrillation.
    Nelson WW; Desai S; Damaraju CV; Lu L; Fields LE; Wildgoose P; Schein JR
    Curr Med Res Opin; 2014 Dec; 30(12):2437-42. PubMed ID: 25170587
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anticoagulation with warfarin. A review of monitoring issues.
    Vogel E
    Adv Nurse Pract; 2001 Jan; 9(1):75-8, 81, 94. PubMed ID: 12416044
    [No Abstract]   [Full Text] [Related]  

  • 49. Patient Satisfaction With Extended International Normalized Ratio Follow-up Intervals in a Veteran Population.
    Schoen RR; Nagy MW; Porter AL; Margolis AR
    Ann Pharmacother; 2020 May; 54(5):442-449. PubMed ID: 31752504
    [No Abstract]   [Full Text] [Related]  

  • 50. Randomized Comparison of Two Approaches to Initial Warfarin Dosing: Time in Therapeutic Range of International Normalized Ratio During Hospitalization.
    Mishchenko LN; Averkov OV; Gordeev IG; Levchuk NN; Vechorko VI
    Kardiologiia; 2018 Nov; 57(9):42-46. PubMed ID: 31713505
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Warfarin therapy: tips and tools for better control.
    Garcia DA; Schwartz MJ
    J Fam Pract; 2011 Feb; 60(2):70-5. PubMed ID: 21301641
    [No Abstract]   [Full Text] [Related]  

  • 52. Chronic atrial fibrillation: optimizing anticoagulation.
    Wheeldon NM
    QJM; 1997 Oct; 90(10):609-11. PubMed ID: 9415341
    [No Abstract]   [Full Text] [Related]  

  • 53. Warfarin and extractions.
    Gibbons AJ; Evans IL; Sayers MS; Price G; Snooks H; Sugar AW
    Br Dent J; 2002 Sep; 193(6):302. PubMed ID: 12368872
    [No Abstract]   [Full Text] [Related]  

  • 54. Evidence for continuing warfarin during dental extractions.
    Gibbons AJ; Sugar AW
    Br Dent J; 2003 Jan; 194(2):65. PubMed ID: 12596735
    [No Abstract]   [Full Text] [Related]  

  • 55. In Potential Stroke Patients on Warfarin, the International Normalized Ratio Predicts Ischemia.
    Cao C; Martinelli A; Spoelhof B; Llinas RH; Marsh EB
    Cerebrovasc Dis Extra; 2017; 7(2):111-119. PubMed ID: 28803231
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Why shouldn't we use warfarin alone to treat acute venous thrombosis?
    Choueiri T; Deitcher SR
    Cleve Clin J Med; 2002 Jul; 69(7):546-8. PubMed ID: 12109637
    [No Abstract]   [Full Text] [Related]  

  • 57. [Summary of the article: Matchar B, Jacobson DB, Dolor R et al. Effect of home testing of international normalized ratio on clinical events. N Engl J Med, 2010; 363: 1608-1620].
    Narkun A
    Kardiol Pol; 2011; 69(5):510-1. PubMed ID: 21594849
    [No Abstract]   [Full Text] [Related]  

  • 58. Dabigatran v warfarin. Compare with higher standard.
    Edwards D
    BMJ; 2010 Oct; 341():c5984. PubMed ID: 20978048
    [No Abstract]   [Full Text] [Related]  

  • 59. Ximelagatran versus warfarin after total knee replacement.
    Schillaci G; Pasqualini L; Mannarino E
    N Engl J Med; 2004 Feb; 350(6):616-7; author reply 616-7. PubMed ID: 14768067
    [No Abstract]   [Full Text] [Related]  

  • 60. Bleeding risk in warfarinized patients with a therapeutic international normalized ratio: the effect of low factor IX levels.
    Dargaud Y; Hoffman M; Lefrapper L; Lin FC; Genty A; Chatard B; Marin S; Négrier C; Monroe DM
    J Thromb Haemost; 2013 Jun; 11(6):1043-52. PubMed ID: 23581252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.